SK
Sky Century Investment, Inc.
SKYI · OTC
$0.07 +29.37% (+$0.02)
1M -32.57%
Market Cap $150.7K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.1
48.4% upside
Current Price
$0.067
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SKYI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 1.19x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Rev. growth 19.07%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 102.42%
Op. margin 49.48%
Gross margin 52.92%
Quality
75 /100
Excellent ROA 48.57%
Asset turnover 0.98x
ROIC 77.64%
Debt
0 /100
High Current ratio 0.04x
Debt/Assets N/A
Net debt/EBITDA N/A
Stability
32 /100
Unstable Profitable years 0
EPS volatility 12.83%
Beta 1.87x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SKYI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nataliia Petranetska
Employees
1
Headquarters
Las Vegas